Analysis of the Effectiveness of Blotting Assays for Donor Blood Screening.
- Author:
Deok Ja OH
1
;
Jae Won KANG
;
Yoon Mee PARK
Author Information
1. Central Blood Laboratory Center, Korean Red Cross, Seoul, Korea. dj57_2000@redcross.or.kr
- Publication Type:Original Article
- Keywords:
Immunoblot assay;
Indeterminate (ID);
Donor screening process
- MeSH:
Blood Donors;
Donor Selection;
Ethics Committees, Research;
Follow-Up Studies;
Humans;
Immunoassay;
Information Management;
Mass Screening;
Red Cross;
Tissue Donors;
Uronic Acids
- From:Korean Journal of Blood Transfusion
2011;22(1):1-8
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Immunoblot assays (IBAs) have been widely used to confirm the reactivity of immunoassay. However, indeterminate (ID) results have shown the limits for interpreting IBAs. There is some debate about the benefit of these assays. We assessed the actual status of the IBAs for the donor screening process and we proposed more available algorithms. METHODS: We analyzed the data from the blood information management system of the Korean Red Cross. This study was approved by the Institutional Review Board of the KRC. The analyzed data included the present condition of various utilities and the results of the IBAs in the world. RESULTS: The infectivity of the ID results in IBAs seemed not to be high, but the safety could not be assured. IBA for HTLV was used as a confirmatory test in many countries. Most of the eligible blood donors could be saved by IBAs. CONCLUSION: IBAs seem to be valuable methods as supplemental and follow up tests for ID results. Furthermore, IBAs were useful to distinguish eligible blood donors. When donors show positive results on an immunoassay and NAT (HIV and HCV) concurrently, then IBA does not seem to be required. Only a RIBA for HCV is recommended for the donors showing a S/CO ratio above 2.0 on immunoassay. The additional alternative immunoassay would be effective in the HTLV screening algorithm.
